The Supreme Court has agreed to review a case challenging the FDA’s refusal to approve flavored e-cigarettes, a decision seen as pivotal amid concerns over teen vaping. E-cigarette manufacturers, including Triton Distribution and Vapestasia, took their cases to court after the FDA declined to approve their products, citing potential health risks, particularly among youth. The… Continue reading Supreme Court to weigh FDA’s refusal to approve flavored vapes

The Food and Drug Administration (FDA) has granted approval to Eli Lilly’s Alzheimer’s drug donanemab, branded as Kisunla, marking a significant advancement in the treatment landscape for early symptomatic Alzheimer’s disease in the U.S. This approval comes as a boon amidst the increasing prevalence of Alzheimer’s, affecting nearly 7 million Americans and projected to rise… Continue reading FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

Toronto, Ontario – TheNewswire – July 2, 2024– Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”, (TSXV:VPT) further to Ventripoint’s press release dated May 13, 2024 announcing the closing of the first tranche of the previously announced non-brokered private placement (the “Offering”) of unsecured debentures (“Debentures”) which raised gross proceeds of $941,000, Ventripoint is pleased to… Continue reading Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering

HALIFAX, Nova Scotia, July 02, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, announces that it has entered into an amending agreement (the “Amending Agreement”) among the Company, Aditxt, Inc. (“Aditxt”) and Adivir, Inc. (“Adivir”… Continue reading Appili Therapeutics Announces Amendment to Arrangement Agreement and Increase to Bridge Loan

U.S. crude oil is set for its third consecutive weekly gain amid escalating tensions between Israel and the Iran-backed militia Hezbollah, heightening fears of a broader conflict in the region. On Friday, West Texas Intermediate (WTI) briefly surged to an intraday high of $82.72 per barrel, its highest level since April 30. Similarly, Brent crude… Continue reading U.S. crude oil heads to third straight weekly gain as fears grow of Israel-Hezbollah war

Just days before the prestigious Henley Regatta, alarming levels of harmful E.coli bacteria have been detected in the River Thames, prompting serious health concerns among anti-pollution campaigners. The international rowing event, which attracts around 4,000 rowers for 400 races, is scheduled to begin on Tuesday. Water quality testing by the River Action campaign group found… Continue reading ‘Alarmingly high’: E.coli levels discovered in River Thames ahead of famous regatta

Pfizer experienced a dramatic first quarter, as its stock surged 6% after surpassing analyst expectations and raising its full-year forecast. This marked a significant recovery from a challenging previous year when Pfizer’s shares plummeted over 40%, drastically reducing its market cap from a 2021 peak of nearly $350 billion to around $157 billion. The pharmaceutical… Continue reading Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

Starbucks has launched a new beverage called Iced Energy across its U.S. stores, a move that comes amidst a burgeoning market for high-caffeine, functional beverages. Each serving of Iced Energy contains between 180 to 205 milligrams of caffeine, making it comparable to six cans of Coke and significantly more potent than a standard Starbucks Caffe… Continue reading Starbucks debuts fruity energy drink less than two months after Panera discontinues highly caffeinated Charged Lemonade

Novo Nordisk announced a $4.1 billion investment to build a new manufacturing plant in Clayton, North Carolina, aiming to boost the supply of its popular weight loss drug Wegovy and diabetes treatment Ozempic, along with other injectable therapies. The Danish pharmaceutical company has faced significant demand for these drugs, leading to intermittent shortages in the… Continue reading Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

The Supreme Court declined to hear two Covid-related appeals brought by Children’s Health Defense, an anti-vaccine group founded by Robert F. Kennedy Jr. The first case challenged the FDA’s emergency authorization of Covid-19 vaccines in December 2020, with the group arguing the vaccines were ineffective and not properly vetted. The 5th U.S. Circuit Court of… Continue reading Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots

Toronto, Ontario – TheNewswire – June 24, 2024 –Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT); (OTC:VPTDF) has been selected to present its AI-enhanced cardiac ultrasound technology, which generates MRI-quality cardiac measurements in minutes, to health-care leaders at The Data Effect on June 25th in Vancouver.  CEO Hugh MacNaught will be on the panel Accelerating AI Startups in Canadian Health Care, which explores applications of… Continue reading Ventripoint to Present its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect

Gilead announced significant success in a late-stage trial for its experimental HIV preventive treatment, lenacapavir, which proved 100% effective among approximately 2,000 women who received the twice-yearly shot. This outcome led an independent data monitoring committee to recommend unblinding the Phase 3 trial and offering the treatment to all participants, surpassing the effectiveness of standard… Continue reading Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial